Human γδ T cells induce CD8+ T cell antitumor responses via antigen-presenting effect through HSP90-MyD88-mediated activation of JNK

被引:6
作者
Wang, Shengdong [1 ,2 ,3 ]
Li, Hengyuan [1 ,2 ,3 ]
Chen, Tao [1 ,2 ,3 ]
Zhou, Hao [1 ,2 ,3 ]
Zhang, Wenkan [1 ,2 ,3 ]
Lin, Nong [1 ,2 ,3 ]
Yu, Xiaohua [1 ,2 ,3 ]
Lou, Yu [4 ]
Li, Binghao [1 ,2 ,3 ]
Yinwang, Eloy [1 ,2 ,3 ]
Wang, Zenan [1 ,2 ,3 ]
Wang, Keyi [1 ,2 ,3 ]
Xue, Yucheng [1 ,2 ,3 ]
Qu, Hao [1 ,2 ,3 ]
Lin, Peng [1 ,2 ,3 ]
Sun, Hangxiang [1 ,2 ,3 ]
Teng, Wangsiyuan [1 ,2 ,3 ]
Mou, Haochen [1 ,2 ,3 ]
Chai, Xupeng [1 ,2 ,3 ]
Cai, Zhijian [5 ]
Ye, Zhaoming [1 ,2 ,3 ]
机构
[1] Second Affiliated Hosp Zhejiang Univ Sch Med, Musculoskeletal Tumor Ctr, Dept Orthoped, Hangzhou 310009, Peoples R China
[2] Zhejiang Univ, Inst Orthoped Res, Hangzhou 310009, Peoples R China
[3] Key Lab Motor Syst Dis Res & Precis Therapy Zhejia, Hangzhou, Zhejiang, Peoples R China
[4] Zhejiang Univ Sch Med, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Hangzhou, Peoples R China
[5] Zhejiang Univ Sch Med, Affiliated Hosp 2, Inst Immunol, Dept Orthopaed, Hangzhou 310009, Peoples R China
基金
中国国家自然科学基金;
关键词
gamma delta T cells; Antigen presentation; Tumor immunotherapy; Osteosarcoma; CROSS-PRESENTATION; TUMOR-ANTIGEN; LINES; IMMUNOTHERAPY; MECHANISM; VACCINES; CD4(+);
D O I
10.1007/s00262-023-03375-w
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human V gamma 9V delta 2 T cells have attracted considerable attention as novel alternative antigen-presenting cells (APCs) with the potential to replace dendritic cells in antitumor immunotherapy owing to their high proliferative capacity and low cost. However, the utility of gamma delta T cells as APCs to induce CD8(+) T cell-mediated antitumor immune response, as well as the mechanism by which they perform APC functions, remains unexplored. In this study, we found that activated V gamma 9V delta 2 T cells were capable of inducing robust CD8(+) T cell responses in osteosarcoma cells. Activated gamma delta T cells also effectively suppressed osteosarcoma growth by priming CD8(+) T cells in xenograft animal models. Mechanistically, we further revealed that activated gamma delta T cells exhibited increased HSP90 production, which fed back to upregulate MyD88, followed by JNK activation and a subsequent improvement in CCL5 secretion, leading to enhanced CD8(+) T cell cross-priming. Thus, our study suggests that V gamma 9V delta 2 T cells represent a promising alternative APC for the development of gamma delta T cell-based tumor immunotherapy.
引用
收藏
页码:1803 / 1821
页数:19
相关论文
共 51 条
[31]   EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumors [J].
Neumann, Frank ;
Kaddu-Mulindwa, Dominic ;
Widmann, Thomas ;
Preuss, Klaus-Dieter ;
Held, Gerhard ;
Zwick, Carsten ;
Roemer, Klaus ;
Pfreundschuh, Michael ;
Kubuschok, Boris .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (07) :1211-1222
[32]   Heat shock protein 90 inhibition abrogates TLR4-mediated NF-κB activity and reduces renal ischemia-reperfusion injury [J].
O'Neill, Stephen ;
Humphries, Duncan ;
Tse, George ;
Marson, Lorna P. ;
Dhaliwal, Kevin ;
Hughes, Jeremy ;
Ross, James A. ;
Wigmore, Stephen J. ;
Harrison, Ewen M. .
SCIENTIFIC REPORTS, 2015, 5
[33]   Comparison of a Novel Bisphosphonate Prodrug and Zoledronic Acid in the Induction of Cytotoxicity in Human Vγ2Vδ2 T Cells [J].
Okuno, Daisuke ;
Sugiura, Yuki ;
Sakamoto, Noriho ;
Tagod, Mohammed S. O. ;
Iwasaki, Masashi ;
Noda, Shuto ;
Tamura, Akihiro ;
Senju, Hiroaki ;
Umeyama, Yasuhiro ;
Yamaguchi, Hiroyuki ;
Suematsu, Makoto ;
Morita, Craig T. ;
Tanaka, Yoshimasa ;
Mukae, Hiroshi .
FRONTIERS IN IMMUNOLOGY, 2020, 11
[34]   Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells [J].
Rapoport, Aaron P. ;
Aqui, Nicole A. ;
Stadtmauer, Edward A. ;
Vogl, Dan T. ;
Xu, Yin Yan ;
Kalos, Michael ;
Cai, Ling ;
Fang, Hong-Bin ;
Weiss, Brendan M. ;
Badros, Ashraf ;
Yanovich, Saul ;
Akpek, Gorgun ;
Tsao, Patricia ;
Cross, Alan ;
Mann, Dean ;
Philip, Sunita ;
Kerr, Naseem ;
Brennan, Andrea ;
Zheng, Zhaohui ;
Ruehle, Kathleen ;
Milliron, Todd ;
Strome, Scott E. ;
Salazar, Andres M. ;
Levine, Bruce L. ;
June, Carl H. .
CLINICAL CANCER RESEARCH, 2014, 20 (05) :1355-1365
[35]   The role of chemokine receptors in primary, effector, and memory immune responses [J].
Sallusto, F ;
Mackay, CR ;
Lanzavecchia, A .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :593-+
[36]   Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy [J].
Sanchez-Paulete, A. R. ;
Teijeira, A. ;
Cueto, F. J. ;
Garasa, S. ;
Perez-Gracia, J. L. ;
Sanchez-Arraez, A. ;
Sancho, D. ;
Melero, I. .
ANNALS OF ONCOLOGY, 2017, 28 :44-55
[37]   Molecular Mechanisms of TLR2-Mediated Antigen Cross-Presentation in Dendritic Cells [J].
Shen, Kuan-Yin ;
Song, Ying-Chyi ;
Chen, I-Hua ;
Leng, Chih-Hsiang ;
Chen, Hsin-Wei ;
Li, Hui-Ju ;
Chong, Pele ;
Liu, Shih-Jen .
JOURNAL OF IMMUNOLOGY, 2014, 192 (09) :4233-4241
[38]   Increased effector γδ T cells with enhanced cytokine production are associated with inflammatory abnormalities in severe hand, foot, and mouth disease [J].
Shen, Yanxi ;
Pan, Zhaojun ;
Zhang, Li ;
Xue, Wei ;
Peng, Mingli ;
Hu, Peng ;
Xu, Hongmei ;
Chen, Min .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 73 :172-180
[39]   γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer [J].
Silva-Santos, Bruno ;
Mensurado, Sofia ;
Coffelt, Seth B. .
NATURE REVIEWS CANCER, 2019, 19 (07) :392-404
[40]   Molecular Determinants of Target Cell Recognition by Human γδ T Cells [J].
Simoes, Andre E. ;
Di Lorenzo, Biagio ;
Silva-Santos, Bruno .
FRONTIERS IN IMMUNOLOGY, 2018, 9